Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis

Circulation

Volumn 135, Issue 2, 2017, Pages 201-203

  Golwala, Harsh ^a   Bajaj, Navkaranbir Singh ^a   Arora, Garima ^b   Arora, Pankaj ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Arrhythmias, cardiac; Cardiomyopathies; Defibrillators, implantable

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MORTALITY; HEART EJECTION FRACTION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LETTER; META ANALYSIS (TOPIC); NONISCHEMIC CARDIOMYOPATHY; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SECONDARY PREVENTION; SUDDEN CARDIAC DEATH; SURVIVAL; THERAPY EFFECT; CARDIOMYOPATHY; CARDIOVERSION; CAUSE OF DEATH; META ANALYSIS; MORTALITY; TREATMENT OUTCOME;

CARDIOMYOPATHIES; CAUSE OF DEATH; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; HUMANS; MORTALITY; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 85007180327     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.116.026056     Document Type: Letter

References (5)

1. Nanthakumar K, Epstein AE, Kay GN, Plumb VJ, Lee DS. Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials. J Am Coll Cardiol. 2004;44:2166-2172. doi: 10.1016/j.jacc.2004.08.054.
2. Desai AS, Fang JC, Maisel WH, Baughman KL. Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. JAMA. 2004;292:2874-2879. doi: 10.1001/jama.292.23.2874.
3. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; Heart Rhythm Society. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2013;127:e283-e352. doi: 10.1161/CIR.0b013e318276ce9b.
4. Køber L, Thune JJ, Nielsen JC, Haarbo J, Videbæk L, Korup E, Jensen G, Hildebrandt P, Steffensen FH, Bruun NE, Eiskjær H, Brandes A, Thøgersen AM, Gustafsson F, Egstrup K, Videbæk R, Hassager C, Svendsen JH, Høfsten DE, Torp-Pedersen C, Pehrson S; DANISH Investigators. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375:1221-1230. doi: 10.1056/NEJMoa1608029.
5. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342:1077-1084. doi: 10.1056/NEJM200004133421502.